JPML Sends Opana Pay-For-Delay Suits To Illinois
Six putative class actions alleging Endo Pharmaceuticals Inc. paid Impax Laboratories Inc. more than $112 million to delay a generic version of Endo's opioid pain medication Opana ER were consolidated in...To view the full article, register now.
Already a subscriber? Click here to view full article